MSB 8.84% $1.36 mesoblast limited

Cell Therapy News/Articles, page-17647

  1. 470 Posts.
    lightbulb Created with Sketch. 465
    Call me glass half full, we probably wouldn’t have ended up where we are today if it had not been for the setback of 2020.

    We wouldn’t have been able to look at the synergistic effects of MSC and MPC cell therapies the way we are now. This is truly momentous.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.